Fig. 3: Proportion of patients that underwent genomic testing with Oncotype DX according to age.
From: Clinical utility of genomic signatures in young breast cancer patients: a systematic review
Fig. 3: Proportion of patients that underwent genomic testing with Oncotype DX according to age. | npj Breast Cancer
